cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rubius Therapeutics Inc
25 own
26 watching
Current Price
$0.28
$-0.02
(-5.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
25.16M
52-Week High
52-Week High
6.54
52-Week Low
52-Week Low
0.14
Average Volume
Average Volume
0.56M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
129.7053
iconMarket Capitalization25.16M
icon52-Week High6.54
icon52-Week Low0.14
iconAverage Volume0.56M
iconDividend Yield--
iconP/E Ratio129.7053
What does the Rubius Therapeutics Inc do?
N/A
Read More
How much money does Rubius Therapeutics Inc make?
News & Events about Rubius Therapeutics Inc.
PR Newswire
3 months ago
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
PR Newswire
4 months ago
Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? PR Newswire NEW YORK, Sept. 23, 2022 NEW YORK...
Globe Newswire
4 months ago
CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases, today announced that Pablo J. ...
PR Newswire
4 months ago
Thinking about buying stock in Mullen Automotive, American Virtual Cloud Technologies, IVERIC Bio, Rubius Therapeutics, or Globalstar? Thinking about buying stock in Mullen Automotive, American Virtual Cloud Technologies, IVERIC Bio, Rubius Therapeutics, or Globalstar? PR Newswire NEW YORK, Sept...
Benzinga
5 months ago
Rubius Therapeutics's (NASDAQ:RUBY) short percent of float has risen 27.45% since its last report. The company recently reported that it has 3.52 million shares sold short, which is 10.54% of all regular shares that are available for trading. read more...
Frequently Asked Questions
Frequently Asked Questions
What is Rubius Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Rubius Therapeutics Inc shares?
plus_minus_icon
How can I buy Rubius Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Rubius Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rubius Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Rubius Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Rubius Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rubius Therapeutics Inc?
plus_minus_icon
What percentage is Rubius Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rubius Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.28
$-0.02
(-5.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SOLID BIOSCIENCES INC
SOLID BIOSCIENCES INC
$7.64
$0.13 (1.73 %)
ORCHARD THERAPEUTICS PLC
ORCHARD THERAPEUTICS PLC
$0.58
$0.01 (1.53 %)
GAMIDA CELL LTD
GAMIDA CELL LTD
$1.71
$0.04 (2.40 %)
AVROBIO INC
AVROBIO INC
$0.93
$-0.01 (-1.06 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
SOLID BIOSCIENCES INC
SOLID BIOSCIENCES INC
$7.64
$0.13 (1.73 %)
ORCHARD THERAPEUTICS PLC
ORCHARD THERAPEUTICS PLC
$0.58
$0.01 (1.53 %)
GAMIDA CELL LTD
GAMIDA CELL LTD
$1.71
$0.04 (2.40 %)
AVROBIO INC
AVROBIO INC
$0.93
$-0.01 (-1.06 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00